Furukawa, Fukumi, Takatsuki Red Cross Hospital, Japan
-
Vol 1, No 1 (Published) - Editorial
From the desk of the Editor-in-Chief: Welcome to the first issue of Trends in Immunotherapy
Details PDF -
Vol 1, No 1 (Published) - Editorial
Hydroxychloroquine in lupus erythematosus, a new horizon of the old drug
Details PDF -
Vol 2, No 1 (Published) - Case Report
Transient effectiveness of dapsone for skin lesions in a patient with discoid lupus erythematosus
Abstract PDF -
Vol 2, No 1 (Published) - Editorial
New horizon of cancer vaccine therapy using dendritic cells made from pluripotent pluripotent stem cells
Details PDF -
Vol 2, No 1 (Published) - Commentary
Dapsone and NETs
Details PDF -
Vol 2, No 1 (Published) - Commentary
Alopecia and IgG4-related disease
Details PDF -
Vol 2, No 1 (Published) - Editorial
Immune checkpoint inhibitors and irAEs
Details PDF -
Vol 2, No 1 (Published) - Editorial
The Nobel Prize in Physiology or Medicine 2018 was awarded to Cancer Therapy by Inhibition of Negative Immune Regulation
Abstract PDF -
Vol 2, No 1 (Published) - Commentary
Antinuclear antibodies in Nakajo-Nishimura syndrome. A bridge with research on refractory autoimmune diseases
Abstract PDF -
Vol 3, No 1 (Published) - Editorial
CAR-T therapy is a breakthrough for intractable autoimmune disease?
Details PDF -
Vol 5, No 1: (Published) - Review Article
Hydroxychloroquine for the treatment of cutaneous lupus erythematosus
Abstract PDF